Neslihan Pınar Özateş

9PUBLICATIONS
22CO-AUTHORS
Molecular targetsChemotherapyTraditional Chinese medicine and treatmentsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jun 07, 2026
Temozolomide and ruxolitinib combination modulates miRNA-associated regulatory networks in glioblastoma stem cells.

|May 21, 2026
Effects of adjuvant propofol on antitumoral effects of carboplatin in experimental endometrial cancer: possible epigenetic associations.

|Apr 21, 2026
Correction: The impact of inhibiting the Hippo signaling pathway effector molecule YAP1 on in vitro glioblastoma and glioblastoma stem cells.

|Jan 23, 2026
The impact of inhibiting the Hippo signaling pathway effector molecule YAP1 on in vitro glioblastoma and glioblastoma stem cells.

Neslihan Pinar Ozates, Bakiye Goker Bagca, Aycan Asik

|Nov 05, 2025
Defeating miR-181a-3p may potentiate the effect of paclitaxel on G2/M arrest in breast cancer stem cells.

Aycan Asik, Bakiye Goker Bagca, Neslihan Pinar Ozates

|Dec 02, 2022
Ruxolitinib enhances cytotoxic and apoptotic effects of temozolomide on glioblastoma cells by regulating WNT signaling pathway-related genes.

Bakiye Goker Bagca, Neslihan Pinar Ozates, Cigir Biray Avci

Pageof 2

Frequent Collaborators

6 joint publications

Çığır Biray Avcı

5 joint publications

Bakiye Goker Bagca

4 joint publications

Aycan Asik

3 joint publications

Cumhur Gunduz